Consider Starting a Beta-Blocker for Surgery in High-Risk Patients

New Am College of Cardiology and Am Heart Assn guidelines will clarify when to use beta-blockers for noncardiac surgery.

Beta-blockers reduce nonfatal MI risk in high-risk patients undergoing noncardiac surgery...probably by decreasing cardiac workload.

But this benefit can come at a cost...bradycardia, hypotension, and possibly a higher risk of stroke and death.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote